STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Telefónica Germany Selects Amdocs to Deploy GenAI Use Cases and Extend its Billing Platform

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags

Amdocs (NASDAQ:DOX) announced an expanded, multi‑year collaboration with Telefónica Germany on November 11, 2025, extending Amdocs' billing platform for an additional three years and deploying new GenAI use cases.

The deal adds Amdocs' amAIz Sales Agent to automate personalized up‑sell offers and promote new products, while the billing extension continues support for millions of consumer and enterprise customers across mobile, broadband, TV, and fixed voice.

Amdocs (NASDAQ:DOX) ha annunciato una collaborazione ampliata e pluriennale con Telefónica Germany il 11 novembre 2025, estendendo la piattaforma di fatturazione di Amdocs per altri tre anni e implementando nuovi casi d'uso GenAI. L'accordo aggiunge amAIz Sales Agent di Amdocs per automatizzare offerte di upsell personalizzate e promuovere nuovi prodotti, mentre l'estensione della fatturazione continua a supportare milioni di clienti, consumer ed enterprise, su mobile, banda larga, TV e voce fissa.

Amdocs (NASDAQ:DOX) anunció una colaboración ampliada y de varios años con Telefónica Germany el 11 de noviembre de 2025, ampliando la plataforma de facturación de Amdocs por otros tres años y desplegando nuevos casos de uso de GenAI. El acuerdo añade el amAIz Sales Agent de Amdocs para automatizar ofertas personalizadas de venta adicional y promover nuevos productos, mientras la extensión de facturación continúa brindando soporte a millones de clientes, de consumo y empresariales, en móvil, banda ancha, TV y voz fija.

Amdocs (NASDAQ:DOX)는 2025년 11월 11일 Telefónica Germany와의 확장된 다년 협업을 발표했으며, Amdocs의 청구 플랫폼을 추가로 3년 연장하고 새로운 GenAI 사용 사례를 도입합니다. 이 계약은 amAIz Sales Agent를 도입하여 맞춤형 상향 판매 제안을 자동화하고 신제품을 홍보하며, 청구 확장은 모바일, 초고속 인터넷, TV, 고정 음성에 걸친 수백만 소비자 및 기업 고객을 계속 지원합니다.

Amdocs (NASDAQ:DOX) a annoncé une collaboration élargie et pluriannuelle avec Telefónica Germany le 11 novembre 2025, prolongeant la plateforme de facturation d'Amdocs pour trois années supplémentaires et déployant de nouveaux cas d'utilisation GenAI. L'accord ajoute l'Agent de vente amAIz de Amdocs pour automatiser des offres croisées personnalisées et promouvoir de nouveaux produits, tandis que l'extension de la facturation continue de soutenir des millions de clients consommateurs et entreprises à travers le mobile, le haut débit, la TV et la voix fixe.

Amdocs (NASDAQ:DOX) kündigte am 11. November 2025 eine erweiterte, mehrjährige Zusammenarbeit mit Telefónica Germany an, wodurch Amdocs' Abrechnungsplattform um weitere drei Jahre verlängert und neue GenAI-Anwendungsfälle eingeführt werden. Der Deal ergänzt Amdocs' amAIz Sales Agent, um personalisierte Upsell-Angebote zu automatisieren und neue Produkte zu fördern, während die Abrechnungserweiterung fortgeführt Millionen von Verbraucher- und Geschäftskunden über Mobil-, Breitband-, TV- und Festnetzdienste unterstützt.

Amdocs (NASDAQ:DOX) أعلنت عن تعاون موسع ومتعدد السنوات مع Telefónica Germany في 11 نوفمبر 2025، مما يمدد منصة الفوترة لدى أمدوكس لمدة ثلاث سنوات إضافية ويطلق حالات استخدام GenAI جديدة. تضيف الصفقة amAIz Sales Agent من أمدوكس لأتمتة عروض البيع الإضافي المخصصة والترويج لمنتجات جديدة، بينما يستمر توسيع الفوترة في دعم ملايين العملاء من المستهلكين والشركات عبر الجوال والإنترنت عالي السرعة والتلفزيون والخط الثابت.

Positive
  • Signed three‑year extension of Amdocs billing platform
  • Deployment of amAIz Sales Agent GenAI up‑sell use cases
  • Billing platform continues to support millions of customers
Negative
  • No financial terms disclosed, limiting near‑term investor impact assessment
  • Announcement includes no quantitative revenue or cost guidance

Insights

Expanded multi-year deal scales Amdocs' billing footprint and adds GenAI upsell automation to Telefónica Germany's customer interactions.

Amdocs will extend its billing platform for an additional three years and deploy amAIz Sales Agent GenAI use cases to automate personalized up-sell and product promotion across consumer and enterprise lines. The business effect ties a mission‑critical revenue system (billing) to customer-facing AI features, creating direct operational leverage if deployments run to plan.

The outcome depends on successful integration, data quality, and regulatory compliance in Germany. Scalability risks include billing migration complexity and accuracy of AI-driven offers; implementation delays or errors could reduce expected efficiency gains. The announcement contains no financial metrics, so impact follows contract execution rather than disclosed revenue.

Watch for three concrete items over the next 6–18 months: live rollout dates for GenAI use cases, measured lifts in personalized up-sell conversion or automation rates, and any public statements about billing migration milestones during the three-year extension. These milestones will indicate whether the partnership converts into measurable top-line growth and cost reduction.

Multi-year agreement advances collaboration into new areas of technology and business innovation to drive growth, and automation

JERSEY CITY, NJ / ACCESS Newswire / November 11, 2025 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced an expanded collaboration with Telefónica Germany, one of Germany's largest quad-play service providers, to deploy new GenAI use cases and extend its billing platform for both consumer and enterprise services for an additional three years.

The new GenAI use cases leverage Amdocs' amAIz Sales Agent to enable Telefónica Germany to promote new products and automate personalized up-sell opportunities, improving efficiency while delivering more relevant customer experiences. At the same time, the extension of Amdocs' robust billing platform will ensure the service provider continues to benefit from a field-proven, scalable, and future-ready solution supporting millions of customers across mobile, broadband, TV, and fixed voice services.

"Our collaboration with Amdocs allows us to combine innovation with proven reliability," said Mallik Rao, Chief Technology and Enterprise Business Officer at Telefónica Germany. "We are continuing to rely on a robust billing platform that has already proven its value across our business. By adding most modern GenAI capabilities, we can make even better personalized offers to millions of our customers - and thus further improve the customer experience."

"We are proud to expand our relationship with Telefónica Germany as they leverage our industry-leading generative AI capabilities to deliver innovative experiences for their customers," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "By introducing our amAIz agent capabilities into their use cases and customer engagements, Telefónica Germany will be able to contextualize and personalize customer interactions, positioning them to capture top-line growth, while driving down the associated costs to acquire and serve."

Supporting Resources

About Amdocs

Amdocs empowers the world's leading communications and media companies to accelerate innovation and deliver exceptional customer experiences at scale. Our comprehensive portfolio of software products and services enable service providers to harness the transformative power of artificial intelligence, driving digital modernization, cloud adoption, intelligent network automation, and new revenue opportunities. With our talented people across the globe, we partner with our customers to turn advanced technology into measurable business outcomes, enriching lives and advancing a more connected society. Together, we help those who shape the future to make it amazing. Listed on the NASDAQ Global Select Market, Amdocs reported revenue of $4.53 billion in fiscal 2025.

Amdocs' Forward-Looking Statement

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2024, filed on December 17, 2024, and our Form 6-K furnished for the first quarter of fiscal 2025 on February 18, 2025, and for the second quarter of fiscal 2025 on May 19, 2025, and for the third quarter of fiscal 2025 on August 18, 2025.

Media Contacts

Mario Hajiloizi
Amdocs Public Relations
E-mail: mario.hajiloizi@amdocs.com

Katie Owen
Babel PR for Amdocs
Tel: +44 (0) 7490 131475
E-mail: amdocs@babelpr.com / katie.owen@babelpr.com

SOURCE: Amdocs Management Limited



View the original press release on ACCESS Newswire

FAQ

What did Amdocs announce with Telefónica Germany on November 11, 2025 (DOX)?

Amdocs announced a multi‑year expansion: a three‑year billing platform extension and deployment of GenAI use cases using amAIz.

How will Amdocs' amAIz Sales Agent affect Telefónica Germany customers (DOX)?

amAIz will enable automated, personalized up‑sell offers and product promotions to improve customer relevance and efficiency.

Does the November 11, 2025 deal disclose financial terms for Amdocs (DOX)?

No; the announcement does not include financial terms or a disclosed contract value.

How long will Amdocs continue to support Telefónica Germany's billing platform (DOX)?

The billing platform extension runs for an additional three years from the agreement date.

Which Telefónica Germany services will the Amdocs platform support (DOX)?

The platform will support consumer and enterprise services across mobile, broadband, TV, and fixed voice.
Amdocs Ltd

NASDAQ:DOX

DOX Rankings

DOX Latest News

DOX Latest SEC Filings

DOX Stock Data

8.51B
109.99M
0%
99.05%
4.25%
Software - Infrastructure
Technology
Link
United States
Saint Louis